New Post Public Reply Private Reply Replies (0) Message Board ← Newer Older → stocksonhighalert Oct 5, 2018 at 10:26 AM 74 $RGBP ~ Regen BioPharma, Inc. Determines Its Lead NR2F6 Agonist Ready for Inflammatory Bowel Disease Animal Studies https://finance.yahoo.com/news/regen-biopharm...00491.html Newer Older